Skip to content

Clinical trials

Mastocytosis, Systemic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mastocytosis, Systemic Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20152
20161
20181
20191
20203
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation6
Cogent Biosciences, Inc.2
Novartis Pharmaceuticals2
AB Science1
Allakos Inc.1
Deciphera Pharmaceuticals, LLC1
Patara Pharma1
Telios Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mastocytosis, Systemic15
Leukemia, Mast-Cell6
Mastocytosis6
Hematologic Diseases2
Hypersensitivity2
Immune Complex Diseases2
Immune System Diseases2
Leukemia2
Carcinoma, Non-Small-Cell Lung1
Gastrointestinal Stromal Tumors1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.